Agilon Health, Inc. (AGL) Revenue History
Agilon Health, Inc. (AGL) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2021-12-31 | $1.83B |
| 2022-12-31 | $2.39B |
| 2023-12-31 | $4.32B |
| 2024-12-31 | $6.06B |
| 2025-12-31 | $5.93B |
How AGL compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| OGN | Organon & Co. | $6.22B |
| EW | Edwards Lifesciences Corporation | $6.07B |
| STE | STERIS plc (Ireland) | $5.94B |
| INCY | Incyte Corporation | $5.14B |
| ENSG | The Ensign Group Inc. | $5.06B |
These are five companies in the same sector as AGL with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Agilon Health, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("AGL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | AGL | $97.06 | +0.50% | 0.06M |
| 3 | ||||
| 4 | ||||
| 5 |